GOOD JENNIFER L — SEC Form 4 filings
SEC reporting owner CIK 1229245. 18 Form 4 filings on record with FilingPulse; latest filed 2026-06-25.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2024-02-16 to 2026-06-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 8 filings — 179,558 shares, $4,576,070 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 55.
- Largest priced transaction: sale of 37,241 shares @ $50.45 ($1,878,700) in RHYTHM PHARMACEUTICALS, INC., filed 2024-09-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | Director | 8 | — | 3 legs · 83,500 sh · $4,268,030 | 34 |
| Trevi Therapeutics, Inc. (TRVI) | President & CEO, Director | 10 | — | 8 legs · 96,058 sh · $308,040 | 21 |
Form 4 filings — GOOD JENNIFER L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-25 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,712 · Option exercise (M): 4,712 (derivative) @ $0 · Grant/award (A): 3,691 (derivative) @ $0 · Grant/award (A): 2,324 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 675,000 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 7,037 (derivative) @ $0 · Grant/award (A): 4,712 (derivative) @ $0 | EDGAR |
| 2025-06-23 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 102,000 (derivative) @ $0 | EDGAR |
| 2025-03-25 | 4 | Trevi Therapeutics, Inc. (TRVI) | Option exercise (M): 5,263 @ $1.43 · Sale (S): 5,263 @ $6.58 · Option exercise (M): 5,263 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 54,400 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 811,000 (derivative) @ $0 | EDGAR |
| 2024-09-19 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 15,000 @ $22.93 · Option exercise (M): 9,250 @ $21.37 · Option exercise (M): 7,501 @ $18.99 · Sale (S): 31,751 @ $52.40 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 9,250 (derivative) @ $0 · +1 more | EDGAR |
| 2024-09-11 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 12,900 @ $22.93 · Option exercise (M): 4,305 @ $21.37 · Option exercise (M): 1,736 @ $18.99 · Option exercise (M): 18,300 @ $4.15 · Sale (S): 37,241 @ $50.45 · Option exercise (M): 12,900 (derivative) @ $0 · +3 more | EDGAR |
| 2024-09-09 | 4 | Trevi Therapeutics, Inc. (TRVI) | Option exercise (M): 4,219 @ $1.43 · Sale (S): 4,219 @ $3.03 · Option exercise (M): 1,840 @ $1.43 · Sale (S): 1,840 @ $3.04 · Option exercise (M): 4,219 (derivative) @ $0 · Option exercise (M): 1,840 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | Trevi Therapeutics, Inc. (TRVI) | Option exercise (M): 3,863 @ $1.43 · Sale (S): 3,863 @ $3.02 · Option exercise (M): 10,981 @ $1.43 · Sale (S): 10,981 @ $3.02 · Option exercise (M): 40,277 @ $1.43 · Sale (S): 40,277 @ $3.11 · +3 more | EDGAR |
| 2024-08-28 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 2,100 @ $22.93 · Option exercise (M): 4,945 @ $21.37 · Option exercise (M): 5,763 @ $18.99 · Option exercise (M): 1,700 @ $4.15 · Sale (S): 14,508 @ $50.01 · Option exercise (M): 2,100 (derivative) @ $0 · +3 more | EDGAR |
| 2024-06-25 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Option exercise (M): 3,000 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | RHYTHM PHARMACEUTICALS, INC. (RYTM) | Grant/award (A): 14,000 (derivative) @ $0 · Grant/award (A): 4,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | Trevi Therapeutics, Inc. (TRVI) | Option exercise (M): 25,037 @ $2.19 · Sale (S): 25,037 @ $2.86 · Option exercise (M): 25,037 (derivative) @ $0 | EDGAR |
| 2024-05-14 | 4 | Trevi Therapeutics, Inc. (TRVI) | Option exercise (M): 4,578 @ $2.19 · Sale (S): 4,578 @ $2.90 · Option exercise (M): 4,578 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 630,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1229245 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →